Testing is a crucial component of our global response to COVID-19. The more people we can test for the virus, the better we can understand the threat we’re up against.
The COVID-19 pandemic has presented new challenges and created questions about what life in the office will look like going forward.
The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?
As the global pandemic brings new attention to emerging therapies, the biopharmaceutical industry shouldn’t overlook HVAC design for contamination control.
Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
A lean approach to project execution relies on four steps for success.
There’s a lot to be learned from the COVID-19 pandemic, including how we can be better prepared for future pandemics.
The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.
Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.